Showing results (771-780 of 804) with videos related to

Sort By:
Pageof 81
EMBO Reports|March 6, 2023
SARS-CoV-2-related bat virus behavior in human-relevant models sheds light on the origin of COVID-19Sarah Temmam, Xavier Montagutelli, Cécile Herate, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 31, 2025
French guidelines on systemic treatments for moderate-to-severe psoriasis in adults: Update 2025Marie Masson Regnault, Emilie Brenaut, Marie-Emeline Marniquet, et al.
Nature|February 16, 2022
Bat coronaviruses related to SARS-CoV-2 and infectious for human cellsSarah Temmam, Khamsing Vongphayloth, Eduard Baquero, et al.
The Journal of Physiology|April 11, 2018
Guinea pig models for translation of the developmental origins of health and disease hypothesis into the clinicJanna L Morrison, Kimberley J Botting, Jack R T Darby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular CarcinomaJulien Calderaro, Léa Meunier, Cong Trung Nguyen, et al.
Journal of Hepatology|February 12, 2026
Detection of Esophageal Varices and Prediction of Hepatic Decompensation in Unresectable Hepatocellular Carcinoma using AI: AI Detection of Varices and DecompensationAsier Rabasco Meneghetti, Claudia Campani, Charles Roux, et al.
JHEP Reports : Innovation in Hepatology|March 19, 2026
Atezolizumab-Bevacizumab in Very Elderly With Hepatocellular Carcinoma: Age Alone Is Not a Limiting Factor Except in ALBI Grade 3Chloé Métivier, Claudia Campani, Manon Allaire, et al.
Eclinicalmedicine|April 23, 2026
Effectiveness and safety of selective internal radiation therapy using yttrium-90 glass microspheres for hepatocellular carcinoma: real-world results from the multi-center prospective PROACTIF cohort of 989 patientsBoris Guiu, Clément Bailly, Eric Vibert, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 17, 2018
Improving pregnancy outcomes in humans through studies in sheepJanna L Morrison, Mary J Berry, Kimberley J Botting, et al.
Chinese Medical Journal|October 16, 2020
Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasisLin Cai, Jian-Zhong Zhang, Xu Yao, et al.
Pageof 81